Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-1996 | 04-1996 | 01-1996 | 10-1995 | 07-1995 | |
| Assets | |||||
| Current Assets | |||||
| Inventories | N/A | N/A | 38,849 | N/A | N/A |
| Other current assets | 6,165 | 6,028 | 5,743 | 5,688 | 5,899 |
| TOTAL | $6,165 | $6,028 | $44,592 | $5,688 | $5,899 |
| Non-Current Assets | |||||
| PPE Net | 37,614 | 35,606 | 31,789 | 28,026 | 24,887 |
| Other Non-Current Assets | 4,532 | 4,519 | 4,211 | 3,901 | 3,982 |
| TOTAL | $42,146 | $40,125 | $36,000 | $31,927 | $28,869 |
| Total Assets | $48,311 | $46,153 | $80,592 | $37,615 | $34,768 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,810 | 3,804 | 3,804 | 3,813 | 24,757 |
| Accounts payable and accrued liabilities | 14,182 | 15,047 | 11,231 | 12,724 | 12,809 |
| Accrued Expenses | 7,715 | 7,079 | 6,348 | 6,896 | 7,769 |
| TOTAL | $58,809 | $53,307 | $45,850 | $38,141 | $45,335 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 479 | 512 | 545 | 577 | 608 |
| TOTAL | $2,123 | $2,502 | $2,151 | $2,153 | $1,969 |
| Total Liabilities | $60,932 | $55,809 | $48,001 | $40,294 | $47,304 |
| Shareholders' Equity | |||||
| Common Shares | 55 | 55 | 55 | 55 | 54 |
| Other shareholders' equity | -6,274 | -6,421 | -6,493 | -6,562 | -6,541 |
| TOTAL | $7,465 | $7,195 | $6,934 | $6,611 | $5,716 |
| Total Liabilities And Equity | $68,397 | $63,004 | $54,935 | $46,905 | $53,020 |